Literature DB >> 27224058

Immune checkpoint inhibitors in malignant pleural mesothelioma: promises and challenges.

Giovanni Luca Ceresoli1, Maria Bonomi1, Maria Grazia Sauta1.   

Abstract

Entities:  

Keywords:  Malignant pleural mesothelioma; immune-checkpoint inhibitors; immunotherapy

Mesh：

Year:  2016        PMID： 27224058     DOI： 10.1080/14737140.2016.1191951

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN： 1473-7140            Impact factor:   4.512


× No keyword cloud information.
  3 in total

1.  Nivolumab Immunotherapy in Malignant Mesothelioma: A Case Report Highlighting a New Opportunity for Exceptional Outcomes.

Authors:  Riley G Jones; Felix Karthik; Anushree Dugar; Karthik Kanagarajan; Kalpan Desai; Manish Bhandari
Journal:  Am J Case Rep       Date:  2018-07-04

2.  Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience.

Authors:  Francesco Falanga; Pietro Rinaldi; Cristiano Primiceri; Chandra Bortolotto; Olga Oneta; Francesco Agustoni; Patrizia Morbini; Laura Saracino; Dimitrios Eleftheriou; Federico Sottotetti; Giulia Maria Stella
Journal:  Thorac Cancer       Date:  2022-09-02       Impact factor: 3.223

Review 3.  Oncolytic Viral Therapy for Mesothelioma.

Authors:  Daniel F Pease; Robert A Kratzke
Journal:  Front Oncol       Date:  2017-08-24       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.